35 matches.
- EventsAHLA: Advising Providers – Legal Strategies for AMCs, Physicians, and HospitalsFebruary 5–7, 20242 minute read
- BlogsDEA Issues Second Temporary Extension of COVID-19 Telemedicine Prescribing Flexibilities, Through 20244 minute read
- BlogsCongress May Have a Vision for Psychedelic Regulation in the US5 minute read
- BlogsHHS Recommends Re-Classification of Marijuana as a Schedule III Controlled Substance – A Bellwether for the Future of Cannabis-ness5 minute read
- Firm AnnouncementsEpstein Becker Green Attorneys Recognized by 2024 Best Lawyers for Excellence in the Legal Profession12 minute read
- BlogsDEA to Host Listening Sessions on Remote Prescribing6 minute read
- Employee and Health Benefits One Year After Dobbs
- The Legal Battle Over Mifepristone
- BlogsThe Legal Battle Over Mifepristone10 minute read
- Legal and Regulatory Landscape for Psychedelics as Therapies
- Firm AnnouncementsSusan Gross Sholinsky, Cassandra Labbees, Delia Deschaine Named “Top Women Faculty” for Dobbs-Related Thought Leadership4 minute read
- BlogsThe Wait Is Over . . . Or Is It? DEA’s Proposed Rules Around Telemedicine Prescribing: Initial Impressions and Key Takeaways21 minute read
- EventsNortheast Business Group on Health: The Dobbs Decision—What’s New and What’s Brewing1 minute read
- PublicationsLegal Landscape for Fertility Treatment in the U.S. in the Wake of Dobbs – Some Answers, More Open Questions. What Will 2023 Deliver?4 minute read
- BlogsFDA Issues Orphan Drug Exclusivity Policy That Could Be a Catalyst for Future Litigation8 minute read
- BlogsFDA Issues Final and Draft Guidance Documents Regarding Food Allergen Labeling7 minute read
- Post-Dobbs: Access to Reproductive Health Care and Abortion-Inducing Drugs
- EventsFrom Roe to Dobbs: The Impact of State Abortion Laws on Employers2 minute read
- EventsWorkforce (re)calibrated: Epstein Becker Green’s 41st Annual Workforce Management Briefing4 minute read
- Firm AnnouncementsEpstein Becker Green Attorneys Recognized by 2023 Best Lawyers for Excellence in the Legal Profession11 minute read
- BlogsRecent FDA Enforcement Action Colors Regulatory Landscape for Delta-8 THC Products5 minute read
- BlogsDEA Finalizes Rule Requiring All Registrations and Renewal Applications to Be Completed Online2 minute read
- Is the Dietary Supplement Regulatory Framework Working?
- Federal and State Cannabis Rules Are Moving in Different Directions
- Firm AnnouncementsEpstein Becker Green Receives 2021 Beacon of Justice Award for “Redefining Justice”6 minute read
- Media CoverageDelia Deschaine, Nathaniel Glasser Featured in Q&A on Cannabis Law5 minute read
- Key Considerations for Reshoring U.S. Drug Manufacturing
- PublicationsCannabis Conundrum: Demonstrating “Accepted Medical Use” in a Restricted Research Environment2 minute read
- BlogsDeadline Looms for Responding to DEA’s Proposed Aggregate Production Quotas for 202111 minute read
- Media CoverageDelia Deschaine, Megan Robertson’s Thought Leadership on Cannabis Regulation Featured in Higher Law: “What’s Next: CBD, the FDA, and the White House”3 minute read
- Holding Pattern: Cannabis Industry Waits for FDA Regulatory Rulemaking
- BlogsFDA Issues Draft Guidance on Cannabis Clinical Research and Sends CBD Enforcement Discretion Guidance to OMB for Review8 minute read
- BlogsFederal Courts Say They Will Decide Cases Against CBD Product Manufacturers When the Smoke Clears4 minute read
- BlogsCurrent Good Manufacturing Practices in the Time of COVID-19: FDA Announces New Expectations on Risk Assessment and Risk Management5 minute read
- Firm AnnouncementsSixteen Epstein Becker Green Attorneys Named to 2020 Washington, DC, Super Lawyers and Rising Stars Lists5 minute read